Aytu BioPharma, Inc. (NASDAQ:AYTU – Get Free Report) saw a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 419,400 shares, an increase of 9.5% from the April 30th total of 383,000 shares. Based on an average daily volume of 19,300 shares, the days-to-cover ratio […]
Stonepine Capital Management LLC acquired a new position in Aytu BioPharma, Inc. (NASDAQ:AYTU – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 472,369 shares of the company’s stock, valued at approximately $756,000. Aytu BioPharma accounts for approximately 0.3% of […]
Aytu BioPharma, Inc. (NASDAQ:AYTU – Get Free Report) traded down 4.5% on Thursday . The company traded as low as $1.70 and last traded at $1.70. 11,426 shares changed hands during mid-day trading, a decline of 83% from the average session volume of 67,743 shares. The stock had previously closed at $1.78. Analysts Set New […]
Aytu BioPharma, Inc (NASDAQ:AYTU) Short Interest Down 39 3% in June theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Aytu BioPharma, Inc. (NASDAQ:AYTU – Get Rating) CEO Joshua R. Disbrow acquired 14,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 14th. The shares were acquired at an average cost of $1.86 per share, with a total value of $26,040.00. Following the purchase, the chief executive officer now directly owns […]